Wilms' tumor Recruiting Phase 2 Trials for DB08881 (Vemurafenib)

Also known as: Wilms Tumour / Wilms Tumor / Wilm's Tumor / Wilm's tumour / Nephroma / Nephroblastoma

IndicationStatusPhase
DBCOND0021654 (Wilms' tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03155620Pediatric MATCH: Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic DisordersTreatment
NCT03220035Pediatric MATCH: Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 MutationsTreatment